PHILIP SCHEEL: Open Payments
NPI 1922053305 · REDWAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 7 payments from 4 companies in 2025. Trend: 2023 $317 · 2024 $99 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Indivior Inc. | 1 | $23 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, Ozempic, Kerendia, SUBLOCADE, REPATHA.
Industry payments across CA — which companies pay providers there.
